Diverse Therapeutics Tandem Clinical Research conducts trials across multiple therapeutic areas including GI, pain, ENT, CNS, pediatrics, psychiatry, endocrinology, sleep, dermatology and women’s health, presenting cross-sell opportunities to CRO partners, sponsor groups, and biopharma across varied indications.

Mid-sized Scale With 51-200 employees and annual revenue in the 10–25 million range, Tandem sits in a mid-market niche advantageous for sponsors seeking flexible, attentive site management combined with broader therapeutic reach than small clinics yet more personalized service than large CROs.

Strategic Locations Operates clinics in Marrero and Metairie, Louisiana, and New York City, offering access to diverse patient populations and regional therapeutic incidence, enabling sponsors to optimize site selection for regional trial recruitment and faster enrollment.

Data and Tech Readiness Employs a modern tech stack including AWS, iCIMS, WordPress, Webflow, and advertising platforms, suggesting strong capabilities in data handling, recruitment marketing, and digital patient outreach to accelerate trial timelines.

Competitive Positioning As a multi-therapeutic, independent site with extensive trial experience (350+ trials in Phases I-IV) and a lean-to-mid scale footprint, Tandem can position itself as a flexible, cost-efficient alternative to larger CROs for sponsors prioritizing dedicated site-level focus and diverse patient access.